Myriad Genetics Inc (NASDAQ:MYGN)
| 31.48 BATS BZX Real-Time Price As of 10:34am ET |  -0.08 / -0.25%Today’s Change | 10.54 Today|||52-Week Range 33.97 | +59.19% Year-to-Date |
Latest MYGN News | Press Releases
No recent news for Myriad Genetics Inc.
Today’s Trading
| Previous close | 31.56 |
| Today’s open | 31.73 |
| Day’s range | 31.21 - 31.74 |
| Volume | 4,033 |
| Average volume (3 months) | 587,634 |
| Market cap | $2.2B |
Data as of 10:34am ET, 06/24/2021
Growth & Valuation
| Earnings growth (last year) | -4,389.30% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +6.00% |
| Revenue growth (last year) | -24.97% |
| P/E ratio | NM |
| Price/Sales | 1.32 |
| Price/Book | 2.33 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| LNTHLantheus Holdings In... | +0.51 | +1.96% |
| VCYTVeracyte Inc | +1.46 | +3.74% |
| CLDXCelldex Therapeutics... | +1.94 | +6.46% |
| TRILTrillium Therapeutic... | +0.50 | +4.85% |
Data as of 10:36am ET, 06/24/2021
Financials
| Next reporting date | September 1, 2021 |
| EPS forecast (this quarter) | -$0.10 |
| Annual revenue (last year) | $638.6M |
| Annual profit (last year) | -$199.5M |
| Net profit margin | -31.24% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Salt Lake City, Utah |
Forecasts
